百利天恒:2025年年度业绩快报公告

Group 1 - The core point of the article is that Baili Tianheng announced a significant decline in its financial performance for 2025, with total operating revenue expected to be 2520.11 million yuan, representing a year-on-year decrease of 56.72% [1] - The net profit attributable to the parent company's owners is projected to be -1050.65 million yuan, indicating a substantial loss [1]

BIOKIN PHARMACEUTICAL-百利天恒:2025年年度业绩快报公告 - Reportify